Real-time enrollment status for this multiple myeloma in relapse clinical trial
Current Status
Recruiting
Checked: July 13, 2026 at 10:56 AM UTC
| NCT Number | NCT06225310 |
| Recruiting Status | Recruiting |
| Condition | Multiple Myeloma in Relapse |
| Phase | Clinical Trial |
| Target Enrollment | 30 participants |
| Active Locations | 1 sites in the US |
| Sponsor | Oncotherapeutics |
| Last Updated on CT.gov | January 16, 2025 (Jan 16, 2025) |
As of July 13, 2026: Clinical trial NCT06225310 is currently recruiting participants. This clinical trial study for multiple myeloma in relapse is actively seeking new participants at 1 location across the United States. The study is sponsored by Oncotherapeutics. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06225310 is actively recruiting participants as of July 13, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06225310 was last updated Jan 16, 2025 (January 16, 2025). HelloStudys verifies this status automatically.